# OnCo record aall0434 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/aall0434/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "aall0434", "NCT00408005" ;
  schema:name "COG AALL0434"@en ;
  schema:alternateName "AALL0434"@en ;
  schema:description "AALL0434 was the largest trial ever run in childhood T-cell leukaemia; it showed that adding the drug nelarabine to standard chemotherapy cut relapses, and that most children could be cured without radiation to the brain."@en ;
  schema:url <https://onco.cc/trials/aall0434/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT00408005> ;
  onco:status "positive" ;
  onco:tag "subtype-trials" ;
  onco:phase "3" ;
  onco:cancers <https://onco.cc/cancers/all-paediatric-high-risk/>, <https://onco.cc/cancers/all-leukemia/> ;
  onco:drugs <https://onco.cc/drugs/nelarabine/>, <https://onco.cc/drugs/methotrexate/> ;
  onco:people <https://onco.cc/people/kimberly-dunsmore/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-aall0434-nelarabine-t-all-dunsmore-jco-2020/> .